09 July 2019

Directorate Change

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that David Evans, Chairman of the Company, has retired from the Board due to the continued progression of his muscle-wasting condition (sporadic inclusion body-myositis).  
 
As outlined in today’s announcement of the Company’s Final Results, Chris Brinsmead, currently a non-executive director, will succeed David as Chairman and will be responsible for taking the Company to the next level of its development.

Jamal Rushdy, Chief Executive Officer of Collagen Solutions, commented: “The Board would like to thank David for his invaluable contribution and wish him all the best for the future.”

Enquiries:

Collagen Solutions Plc Contact via Walbrook
Jamal Rushdy, CEO  
Hilary Spence, CFO  
   
Cenkos Securities Plc (Nominated Adviser and Broker) Tel: 0207 397 8900
Giles Balleny / Stephen Keys  
   
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Anna Dunphy Mob: 07876 741 001